Neurotoxic cyanotoxins prevalent in eastern Australian freshwater systems study shows

January 23, 2019

Scientists have confirmed the presence of an amino acid, BMAA, thought to be associated with a higher incidence of neurodegenerative disease, in eastern Australian freshwater systems, and have identified some of the cyanobacterial species responsible for its production.

Detectable levels of BMAA were found in 89% of samples examined, with some samples containing the highest levels ever recorded.

BMAA (β-methylamino-L-alanine) is a toxin produced by cyanobacteria, more commonly known as blue-green algae, which, under the right conditions, grow excessively to form blooms. Such blooms are a regular feature of Australian inland waterways and are increasing due to nutrient run-off, reduced river flows and climate change.

The toxin was first linked to neurodegenerative disease in the 1940s and more recent global studies have implicated BMAA in an increased incidence of amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND) worldwide.

Eleven freshwater sites from across NSW, including lakes streams creeks and dams, were sampled by researchers from The University of Technology (UTS) to see if it was possible to isolate the cyanobacterial species and create single species cultures that could be tested for these toxins.

Associate Professors Ken Rodgers and Simon Mitrovic, who led the study, said that all the sites were associated with regular blooms and many were from areas that have been tentatively linked to increased incidences of neurodegenerative diseases including Griffith in NSW.

Earlier studies from this research team showed that BMAA, and one of its toxic isomers 2,4-DAB, were present in scum samples from Australian freshwater sites but this is the first time the cyanobacterial species responsible for toxin production have been identified.

From the samples in this study, the primary researcher, Jake Violi, was able to establish 19 single-species cyanobacterial cultures and extract the amino acids for analyses.

The research team from UTS which also included Dr Anne Colville used a highly sensitive analytical method known as liquid-chromatography-tandem mass spectrometry to analyse the samples for the toxins.

Of the 19 cyanobacterial isolates 89% had detectable levels of BMAA and the toxin was detected in at least one culture isolated from each location. Some sites sampled included Anzac Creek in Sydney, Lake Wyangan near Griffith and Lostock Dam in the Hunter Region.

"This shows the prevalence of BMAA in Australian freshwater environments and reflects/accords with results from overseas studies," Jake Violi said.

The research, published in Ecotoxicology and Environmental Safety found the highest concentration of BMAA in cyanobacterial isolates reported in the published literature.

The researchers conclude that the prevalence, abundance and high concentrations of the cyanotoxins found in Eastern Australian freshwater environments necessitates ongoing monitoring and analysis so that safe levels can be determined and guidelines established.

University of Technology Sydney

Related Neurodegenerative Disease Articles from Brightsurf:

CLCN6 identified as disease gene for a severe form of lysosomal neurodegenerative disease
A mutation in the CLCN6 gene is associated with a novel, particularly severe neurodegenerative disorder.

Cellular pathway of genetic heart disease similar to neurodegenerative disease
Research on a genetic heart disease has uncovered a new and unexpected mechanism for heart failure.

New ALS guideline establishes national standard for managing neurodegenerative disease
The first Canadian guideline for the care and management of patients with amyotrophic lateral sclerosis (ALS) -- Lou Gehrig's disease -- recommends a patient-focused approach, with attention to holistic and emotional aspects of well-being.

New study reveals undetected rare neurodegenerative disorder that looks like Parkinson's disease
New Singapore study suggests that patients who are carriers of NIID gene mutation may also present with symptoms and signs of Parkinson's disease (PD), and respond to PD drugs.

Designed a new model to predict the life expectancy of a severe neurodegenerative disease
Researchers from IDIBELL, the University of Göttingen and the University of Münster, designed six tables, using data available at the time of diagnosis, where easily extrapolate patient's life expectancy.

AI-analyzed blood test can predict the progression of neurodegenerative disease
A new study shows artificial intelligence (AI) analysis of blood samples can predict and explain disease progression, which could one day help doctors choose more appropriate and effective treatments for patients.

New study sheds light into origins of neurodegenerative disease
New research has shed light on the origins of spinocerebellar ataxia type 7 (SCA7) and demonstrates effective new therapeutic pathways for SCA7 and the more than 40 other types of spinocerebellar ataxia.

Protein aggregation: Protein assemblies relevant not only for neurodegenerative disease
Amyloid fibrils play a crucial role in neurodegenerative illnesses. Scientists from Heinrich Heine University Düsseldorf (HHU) and Forschungszentrum Jülich have now been able to use cryo-electron microscopy (cryo-EM) to decode the spatial structure of the fibrils that are formed from PI3K SH3 domains - an important model system for research.

Temple researchers: Sorting protein in neurons defends against neurodegenerative disease
Like a sorting machine in an assembly line, a molecule known as VPS35 detects and removes defective proteins from neurons.

How mutations lead to neurodegenerative disease
Scientists have discovered how mutations in DNA can cause neurodegenerative disease.

Read More: Neurodegenerative Disease News and Neurodegenerative Disease Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to